Alopecia Universalis: Partial Response to Tofacitinib

    July 2019 in “ Medicina Clínica (English Edition) ”
    Ricardo Ruíz‐Villaverde, Carlos Cuenca‐Barrales, Laura Linares‐González, Teresa Ródenas‐Herranz
    Studysummary Tofacitinib partially improved hair regrowth in a patient with severe hair loss.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on sciencedirect.com →
    Discuss this study in the Community →

    Related research 7

    1. Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth Cutis · 2023
    2. Alopecia Areata Flare Patterns in Children and Young Adults on Systemic Tofacitinib Journal of the American Academy of Dermatology · 2021
    3. Alopecia Universalis: Partial Response to Tofacitinib Medicina Clínica (English Edition) · 2019
    4. Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A Promising Therapy for the Treatment of Alopecia Areata: A Case Report of Six Patients International Journal of Trichology · 2018
    5. Brazilian Experience of Treating Alopecia Universalis with Novel Antirheumatic Therapy Tofacitinib: A Case Series Rheumatology and Therapy · 2017
    6. Alopecia Universalis Successfully Treated With Tofacitinib Journal of the American Academy of Dermatology · 2017
    7. Excellent Response to Tofacitinib Treatment in a Patient with Alopecia Universalis Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.) · 2017